These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A novel missense mutation of ABCA1 in transmembrane alpha-helix in a Japanese patient with Tangier disease. Maekawa M; Kikuchi J; Kotani K; Nagao K; Odgerel T; Ueda K; Kawano M; Furukawa Y; Sakurabayashi I Atherosclerosis; 2009 Sep; 206(1):216-22. PubMed ID: 19344898 [TBL] [Abstract][Full Text] [Related]
8. ABCA1 and nascent HDL biogenesis. Wang S; Smith JD Biofactors; 2014; 40(6):547-54. PubMed ID: 25359426 [TBL] [Abstract][Full Text] [Related]
10. The roles of C-terminal helices of human apolipoprotein A-I in formation of high-density lipoprotein particles. Nagao K; Hata M; Tanaka K; Takechi Y; Nguyen D; Dhanasekaran P; Lund-Katz S; Phillips MC; Saito H Biochim Biophys Acta; 2014 Jan; 1841(1):80-7. PubMed ID: 24120703 [TBL] [Abstract][Full Text] [Related]
11. Do DNA sequence variants in ABCA1 contribute to HDL cholesterol levels in the general population? Pajukanta P J Clin Invest; 2004 Nov; 114(9):1244-7. PubMed ID: 15520856 [TBL] [Abstract][Full Text] [Related]
12. Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL. Soro-Paavonen A; Naukkarinen J; Lee-Rueckert M; Watanabe H; Rantala E; Soderlund S; Hiukka A; Kovanen PT; Jauhiainen M; Peltonen L; Taskinen MR J Lipid Res; 2007 Jun; 48(6):1409-16. PubMed ID: 17372331 [TBL] [Abstract][Full Text] [Related]
13. HDL, cholesterol efflux, and ABCA1: Free from good and evil dualism. Ogura M J Pharmacol Sci; 2022 Oct; 150(2):81-89. PubMed ID: 36055755 [TBL] [Abstract][Full Text] [Related]
14. Two novel missense mutations in ABCA1 result in altered trafficking and cause severe autosomal recessive HDL deficiency. Albrecht C; Baynes K; Sardini A; Schepelmann S; Eden ER; Davies SW; Higgins CF; Feher MD; Owen JS; Soutar AK Biochim Biophys Acta; 2004 May; 1689(1):47-57. PubMed ID: 15158913 [TBL] [Abstract][Full Text] [Related]
15. Binding of PDZ-RhoGEF to ATP-binding cassette transporter A1 (ABCA1) induces cholesterol efflux through RhoA activation and prevention of transporter degradation. Okuhira K; Fitzgerald ML; Tamehiro N; Ohoka N; Suzuki K; Sawada J; Naito M; Nishimaki-Mogami T J Biol Chem; 2010 May; 285(21):16369-77. PubMed ID: 20348106 [TBL] [Abstract][Full Text] [Related]
16. ABCA1 contributes to macrophage deposition of extracellular cholesterol. Jin X; Freeman SR; Vaisman B; Liu Y; Chang J; Varsano N; Addadi L; Remaley A; Kruth HS J Lipid Res; 2015 Sep; 56(9):1720-6. PubMed ID: 26203076 [TBL] [Abstract][Full Text] [Related]
17. Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1. Abdel-Razek O; Sadananda SN; Li X; Cermakova L; Frohlich J; Brunham LR J Clin Lipidol; 2018; 12(1):116-121. PubMed ID: 29150341 [TBL] [Abstract][Full Text] [Related]
18. Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro. Hafiane A; Bielicki JK; Johansson JO; Genest J PLoS One; 2015; 10(7):e0131997. PubMed ID: 26207756 [TBL] [Abstract][Full Text] [Related]
19. ATP-Binding Cassette Transporter A1 Deficiency in Human Induced Pluripotent Stem Cell-Derived Hepatocytes Abrogates HDL Biogenesis and Enhances Triglyceride Secretion. Bi X; Pashos EE; Cuchel M; Lyssenko NN; Hernandez M; Picataggi A; McParland J; Yang W; Liu Y; Yan R; Yu C; DerOhannessian SL; Phillips MC; Morrisey EE; Duncan SA; Rader DJ EBioMedicine; 2017 Apr; 18():139-145. PubMed ID: 28330813 [TBL] [Abstract][Full Text] [Related]
20. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease. Neufeld EB; Stonik JA; Demosky SJ; Knapper CL; Combs CA; Cooney A; Comly M; Dwyer N; Blanchette-Mackie J; Remaley AT; Santamarina-Fojo S; Brewer HB J Biol Chem; 2004 Apr; 279(15):15571-8. PubMed ID: 14747463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]